Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance

Dolby Laboratories, Inc.Trade
ProShares UltraPro QQQ ETFTrade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs ProShares UltraPro QQQ ETF — how do they compare? Dolby Laboratories, Inc. trades at $58.76 (market cap $5.47B), while ProShares UltraPro QQQ ETF trades at $81.15 (market cap $38.74B). The key difference: ProShares UltraPro QQQ ETF is far larger — about 7.1× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.46% dividend while ProShares UltraPro QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and ProShares UltraPro QQQ ETF for 24 Days on average.

DLBTQQQ
Market Cap
$5.47B$38.74B
Volume
1,058,28465,384,797
Sector
TechnologyLeveraged / Inverse
52-Week High
$70.09$87.22
52-Week Low
$48.51$37.89
Typical Hold Time
98 Days24 Days
Enterprise Value
$4.85B—
Dividend Yield
2.46%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

Dolby Laboratories (DLB) trades at $58.67, up 0.55% with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with 87.61% gross margins and 16.7% net income margins, though revenue has remained flat around $1.3B. Recent developments include expanded partnerships with Meta and leadership transition to new CEO Marc Whitten.

DLB offers value with analyst consensus target of $90.33 (54% upside) but faces near-term execution risks and licensing volatility. The stock trades at reasonable valuations (P/E 24.87, P/S 4.15) with solid cash flow generation, though technical indicators suggest caution amid bearish momentum signals.

ProShares UltraPro QQQ ETF

TQQQ trades at $81.16, down 2.92% on the day, with technical indicators showing a bullish overall signal despite recent selling pressure. The leveraged ETF structure amplifies both gains and losses, with recent news highlighting hidden costs beyond the stated 0.82% expense ratio. Support levels are established at $78 and $76, while resistance sits at $83 and $85.

The outlook for TQQQ remains tied to Nasdaq-100 performance and tech sector momentum, though volatility decay and financing costs present significant long-term risks. Current technical positioning suggests potential for near-term upside if support holds, but investors should be cautious of amplified losses during market downturns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLB

No sentiment data available yet.

TQQQ
36% Buy64% Sell
Avg holding period · 24 Days

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB →

About ProShares UltraPro QQQ ETF

TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.

Read more on TQQQ →